Benitec Biopharma Inc (BNTC)
10.66
+0.26
(+2.50%)
USD |
NASDAQ |
Nov 15, 16:00
10.66
0.00 (0.00%)
After-Hours: 20:00
Benitec Biopharma Enterprise Value: 135.23M for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 135.23M |
| November 13, 2024 | 135.95M |
| November 12, 2024 | 143.64M |
| November 11, 2024 | 141.31M |
| November 08, 2024 | 138.45M |
| November 07, 2024 | 141.67M |
| November 06, 2024 | 136.84M |
| November 05, 2024 | 133.80M |
| November 04, 2024 | 142.39M |
| November 01, 2024 | 144.53M |
| October 31, 2024 | 137.20M |
| October 30, 2024 | 138.09M |
| October 29, 2024 | 142.92M |
| October 28, 2024 | 140.96M |
| October 25, 2024 | 145.79M |
| October 24, 2024 | 144.71M |
| October 23, 2024 | 141.13M |
| October 22, 2024 | 140.42M |
| October 21, 2024 | 147.58M |
| October 18, 2024 | 154.55M |
| October 17, 2024 | 149.90M |
| October 16, 2024 | 124.67M |
| October 15, 2024 | 124.67M |
| October 14, 2024 | 130.94M |
| October 11, 2024 | 143.46M |
| Date | Value |
|---|---|
| October 10, 2024 | 124.67M |
| October 09, 2024 | 114.83M |
| October 08, 2024 | 118.41M |
| October 07, 2024 | 50.79M |
| October 04, 2024 | 49.20M |
| October 03, 2024 | 52.69M |
| October 02, 2024 | 56.80M |
| October 01, 2024 | 64.98M |
| September 30, 2024 | 46.14M |
| September 27, 2024 | 46.56M |
| September 26, 2024 | 41.92M |
| September 25, 2024 | 42.02M |
| September 24, 2024 | 43.50M |
| September 23, 2024 | 42.87M |
| September 20, 2024 | 47.30M |
| September 19, 2024 | 40.18M |
| September 18, 2024 | 37.38M |
| September 17, 2024 | 37.80M |
| September 16, 2024 | 34.06M |
| September 13, 2024 | 31.34M |
| September 12, 2024 | 31.44M |
| September 11, 2024 | 34.26M |
| September 10, 2024 | 37.39M |
| September 09, 2024 | 38.60M |
| September 06, 2024 | 40.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.58M
Minimum
Dec 05 2023
242.28M
Maximum
Apr 21 2020
23.52M
Average
5.147M
Median
Nov 04 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.833M |
| Palatin Technologies Inc | 11.39M |
| iBio Inc | 5.346M |
| Theriva Biologics Inc | -13.34M |
| Oragenics Inc | 2.080M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.72M |
| Total Expenses (Quarterly) | 5.548M |
| EPS Diluted (Quarterly) | -0.5293 |
| Earnings Yield | -71.01% |
| Normalized Earnings Yield | -149.20 |